Marimed Inc. (MRMD.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,756 | 3,044 | 2,685 | 2,817 | 2,312 |
| Accounts receivable | -303 | -1,216 | 539 | -1,237 | 707 |
| Accounts payable and accrued liabilities | 86 | -32 | 613 | 2,273 | 1,334 |
| Other Working Capital | 1,757 | 4,571 | -1,191 | 1,335 | 1,704 |
| Other Operating Activity | -3,003 | -6,780 | -1,843 | -2,003 | -2,847 |
| Operating Cash Flow | $1,293 | $-413 | $803 | $3,185 | $3,210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -266 | -1,058 | -2,566 | -4,968 | -3,368 |
| Net Acquisitions | 181 | -100 | 485 | -4,250 | -485 |
| Purchase Of Investment | 0 | 0 | N/A | N/A | -86 |
| Purchase Sale Intangibles | -56 | -49 | -40 | -358 | -265 |
| Other Investing Activity | 26 | 7 | -3 | 33 | -62 |
| Investing Cash Flow | $-115 | $-1,200 | $-2,124 | $-9,543 | $-4,266 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 2,129 | 1,901 | 2,210 |
| Debt Repayment | -1,201 | -874 | -1,175 | -547 | -520 |
| Dividend Paid | -58 | -19 | -37 | -38 | -45 |
| Financing Cash Flow | $-1,259 | $-893 | $917 | $1,316 | $1,645 |
| Beginning Cash Position | 7,282 | 9,788 | 10,192 | 15,234 | 14,645 |
| End Cash Position | 7,201 | 7,282 | 9,788 | 10,192 | 15,234 |
| Net Cash Flow | $-81 | $-2,506 | $-404 | $-5,042 | $589 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,293 | -413 | 803 | 3,185 | 3,210 |
| Capital Expenditure | -322 | -1,107 | -2,606 | -5,326 | -3,633 |
| Free Cash Flow | 971 | -1,520 | -1,803 | -2,141 | -423 |